Upon critical analysis of the management of vaccine trials globally, one can see the role of AI and intelligent automation every step of the way. There has been a cross-border collaboration in discovery, precision in manufacturing, and improved speed in drug lifecycle management. Sharing clinical lifecycle data on the cloud-enabled global pharmaceutical stakeholders to monitor and evaluate parameters of Adverse Events Reporting Systems (AERS) in a unified manner. Trends such as these forced a sudden modernization of the biopharma industry, the outcome of which was seen in metrics of improved personalized care, connected delivery of patient supervision, and standardization of remote care towards the end objective of saving lives.
Being Mindful of Technology, Judiciously Securing the Process of Modernization
Evidently, the adoption of AI and modern technologies of cloud computing can transcend traditional physical boundaries within an organization. Leveraging the Internet of Things (IoT) enables the provision of medical services over connected cloud platforms. Doctors stand to gain in providing secure and private telehealth consultations and oversee patients at scale through holistic patient-centric connected care solutions.
While there is increasing recognition of cloud technologies in healthcare, one cannot simply ignore that the adoption of these new-age technologies may be hampered by concerns of quality assurance, privacy, service reliability, and data integrity. The pandemic context has imbibed a strong sense of purpose in implementing and benefiting from the fast scale-up of cloud-based solutions. Now that the momentum to this compulsion has been established, it is time to be mindful of the risks and compromises associated with the execution of such solutions at speed.
As we weigh and dissect these threats, we cannot simply shy away from cloud technologies overall to repudiate the risks related to them. To this end, it is the additional reliance on blockchain and connected physical platforms that can help pharmaceutical companies take off in the direction of improved healthcare practices, which are secure in the truest sense of the term.